SCHEMBL10106871

SCHEMBL10106871

COc1ccc(/C(C)=N/OCc2ccc(N=O)cc2)cc1OC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 2/20 0.47
PPARA Q07869 2/20 0.47
LMNA P02545 4/20 0.43
HTT P42858 2/20 0.43
MAPT P10636 2/20 0.43
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
CASP3 P42574 1/20 0.43
SENP8 Q96LD8 1/20 0.43
SENP7 Q9BQF6 1/20 0.43
SENP6 Q9GZR1 1/20 0.43
S1PR1 P21453 2/20 0.42
NPC1 O15118 3/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
TSHR P16473 1/20 0.42
CYP2C19 P33261 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
POLB P06746 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10106870 0.91 PDE4B (0.41) PPARGPPARALMNAHTTMAPT
SCHEMBL10106873 0.90 SLC22A6 (0.44) PPARGPPARAHTTKDM4EALDH1A1
SCHEMBL10106822 0.90 TUBB4A (0.42) PPARGPPARALMNAS1PR1NPC1
SCHEMBL10107056 0.89 RAB9A (0.45) PPARGPPARALMNAHTTS1PR1
SCHEMBL10106814 0.83 S1PR1 (0.57) PPARGPPARAHTTMAPTALDH1A1
SCHEMBL10107086 0.81 HTT (0.53) LMNAHTTMAPTALDH1A1S1PR1
SCHEMBL10106876 0.79 PPARG (0.50) PPARGPPARALMNAHTTMAPT
SCHEMBL10106819 0.78 NPC1 (0.63) PPARGPPARALMNAHTTS1PR1
SCHEMBL10107079 0.78 HSP90AA1 (0.39) MAPTKDM4ES1PR1NPC1SMN1; SMN2
SCHEMBL10106872 0.77 CYP3A4 (0.47) LMNAHTTMAPTALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120046255-A1 NON-STEROIDAL COMPOUNDS THE UNIVERSITY OF MELBOURNE of ROYAL PARADE PARKVILLE (AU) 2012-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046255-A1 NON-STEROIDAL COMPOUNDS PTGES2, PTGES, PTGES3 PPARG 171/4885PPARA 317/4885LMNA 2636/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.